Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Curr Respir Care Rep. 2013 Dec;2(4):10.1007/s13665-013-0065-x. doi: 10.1007/s13665-013-0065-x

Table 2.

Management considerations for acute exacerbation of IPF

Intervention Recommendation
Prevention of acute exacerbation of IPF
Influenzae and pneumococcal vaccination +
Hand washing, avoidance of sick contacts +
Behavioral modifications for reflux and aspiration +
Proton pump inhibitor therapy +/−
Minimization of mechanical stress during surgery +
Avoidance of airborne irritants and pollutants +/−
Treatment of acute exacerbation of IPF
Mechanical ventilation +/−
Corticosteroids +
Empiric antibiotics +
Other therapies (tacrolimus, polymixin B hemoperfusion, cyclosporine A, thrombomodulin)
Pharmacological therapies for idiopathic pulmonary fibrosis +/−
Lung transplantation +/−

+ = Would consider using in most patients as potential benefit seems to outweigh potential harm; +/− = Would consider using in selected cases as the balance of benefit and risk varies by clinical situation; − = Would not consider using in most patients as evidence is lacking to support a clinical benefit. Abbreviations: IPF = idiopathic pulmonary fibrosis.